FDA DEVICE FACTS
NG-Test CARBA 5
Ng Biotech
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
NG-Test CARBA 5 is an in vitro rapid and visual multiplex immunochromatographic assay for the qualitative detection and differentiation of five common carbapenemases (KPC, OXA -48-like, VIM, IMP and NDM) from carbapenem non-susceptible pure bacterial colonies when grown on the following media: 5% sheep blood agar or MacConkey agar (16 -24 hours) for testing Enterobacteriaceae and Pseudomonas aeruginosa HardyCHROM™ CRE agar (18-24 hours) for testing E. coli and KES (Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Enterobacter cloacae complex, and Serratia marcescens). The NG-Test CARBA 5 is intended as an aid for infection control in the detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa in healthcare settings. NG-Test CARBA 5 is not intended to guide or monitor treatment for carbapenem non-susceptible bacterial infections. A positive or negative NG-Test CARBA 5 test result does not rule out the presence of other mechanisms of antibiotic resistance. NG-Test CARBA 5 should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。